A research team at Kaiser Permanente Washington Health Research Institute (KPWHRI) has been approved for a $4.75 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study what types of communication and community engagement strategies are most effective at improving uptake of COVID-19 vaccines among workers in long-term care facilities (LTCFs) for older adults and other vulnerable populations.
The study aims to generate evidence that could help raise immunization rates among LTCF workers — a group including populations that generally have experienced more severe illness and death due to COVID-19. These workers are in frequent direct contact with older adults, who, if unvaccinated, face a high risk for becoming severely sick or dying if exposed to the novel coronavirus.
KPWHRI will work in collaboration with Kaiser Permanente of Georgia, University of Washington and the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) affiliated scientists, along with co-investigators with experience working in long-term care facilities. The study will also engage an advisory panel of governmental, industry and policy stakeholders.
“Community engagement and tailored communication strategies are important for addressing vaccine hesitancy, especially for communities such as immigrant/refugee and racial and ethnic groups that experience racism and discrimination in both research and health care,” said Clarissa Hsu, PhD, the KPWHRI assistant investigator who is leading the study. “While people in these communities often trust information and support from their social networks, community-engagement and tailored messaging strategies have yet to be tested to determine their effectiveness at increasing vaccine uptake or feasibility of systematic implementation.”
According to the project summary, the study will be carried out in Georgia and Washington state, with 60 LTCFs, 30 in each state. It will include about 6,000 frontline workers, with a particular focus on cultural or affinity groups that have high rates of hesitancy in order to increase health equity and inclusion. Each LTCF will be randomly assigned to 1 of 3 interventions:
This study is 1 of 2 complementary studies that PCORI announced earlier this week as part of its initiative to assess approaches for increasing COVID-19 vaccine confidence among long-term care workers. This topic was identified as an urgent need following a November 2020 survey, which found that only 45% of long-term care workers were willing to receive a COVID-19 vaccine immediately once available. Evidence generated by these studies may offer useful insights for promoting greater confidence in immunization against other diseases as well.
“This study was selected for PCORI funding not only for its scientific merit and commitment to engaging patients and other stakeholders, but also for its potential to fill an important gap in our health knowledge,” said PCORI Executive Director Nakela L. Cook, MD, MPH. “The study addresses an urgent need as COVID-19 vaccination rates are slowing generally and long-term care workers and those they care for continue to face elevated risks from the novel coronavirus. We look forward to following the study’s progress and working with KPWHRI to share the results.”
This funding award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract.
PCORI is an independent, nonprofit organization initially authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians, and other health care decision makers with the evidence-based information needed to make better-informed health care choices.
Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
Dr. Clarissa Hsu writes about how her team equalized power between patients and staff in a quality improvement project.
Drs. Clarissa Hsu and Marlaine Figueroa Gray asked patients, caregivers, and physicians this question. Here’s what they learned.Drs. Clarissa Hsu and Marlaine Figueroa Gray asked patients, caregivers, and physicians this question. Here’s what they learned.